Zydus Lifesciences received USFDA final approval for 32 mg bosentan tablets for pediatric PAH and Ammonium Lactate Cream, 12%, while launching an affordable respiratory device in India.
Zydus Lifesciences Limited received final FDA approval for Ammonium Lactate Cream, 12%, a generic of Lac-Hydrin Cream. The topical prescription medication treats xerosis and ichthyosis vulgaris, with annual U.S. sales of $15 million.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07183423 |
Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction |
RECRUITING | NA |
| NCT06706050 |
Clinical Therapeutic Potential of Novel Microbiome LP-51 on Xerosis Individual Based on Xerosis-microbiome Index |
COMPLETED | PHASE1/PHASE2 |
| NCT04245319 |
Combined Effect of Acitretin and Narrow Band Ultraviolet B on Vitiligo Repigmentation |
UNKNOWN | NA |
| NCT04181177 |
Efficacy Study of Cosmetic Product on Xerosis Induced by Systemic Anticancer Treatments |
COMPLETED | |
| NCT03497130 |
The Role of Skin Care Regimen in Skin Health |
COMPLETED | NA |
| NCT03093597 |
Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin |
COMPLETED | NA |
| NCT02429206 |
Safety and Efficacy of SQIN™ on Xerosis in Adults With Mobility Problems and Paralysis |
COMPLETED | PHASE2/PHASE3 |
